Welcome to the e-CCO Library!

P388: Risk of relapse in ulcerative colitis patients in clinical remission with combination therapy (anti-TNF and azathioprine) after immunomodulator discontinuation
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mihai C., Dranga M., Gavrilescu O., Ungureanu I., Didita A., Chiosa A.M., Savin A., Popa I., Popa R., Jigaranu O., Cijevschi-Prelipcean C.

Created: Wednesday, 20 February 2019, 10:36 AM
P388: Shear wave elastography predicts short-term response to induction therapy in patients with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sagami, S.(1,2)*;Morikubo, H.(1,2);Miyatani, Y.(1);Fukuda, T.(1,2);Asonuma, K.(1);Maeda, M.(1,2);Yoko, Y.(1,2);Karashima, R.(1,2);Hojo, A.(1,2);Nakano, M.(1,2);Hibi, T.(1);Kobayashi, T.(1,2,3);
Created: Friday, 14 July 2023, 11:05 AM
P389 Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. van Hoeve1, E. Dreesen2, I. Hoffman1, M. Ferrante3, S. Vermeire3

Created: Thursday, 30 January 2020, 10:12 AM
P389: Efficacy and safety of ustekinumab in patients with Crohn’s disease refractory to anti-tumour necrosis factor: real clinical practice
Year: 2021
Source: ECCO'21 Virtual
Authors: Saiz Chumillas, R.M.(1);Alba Hernández, L.(1);Chivato Martín-Falquina, I.(1);Badia Aranda, E.(1);Arias García, M.L.(1);Sicilia Aladrén, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P389: Indicators for inadequate response to advanced therapy in patients with Ulcerative Colitis: results from a medical chart review in the United Kingdom
Year: 2022
Source: ECCO'22
Authors: Lindsay, J.(1);Picker, N.(2);Kromer, D.(2);Smyth, M.(3);Patel, H.(4);
Created: Friday, 11 February 2022, 3:52 PM
P389: Low-dose metronidazole is associated with a decreased rate of endoscopic recurrence of Crohn's disease after ileal resection
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Glick L.*1, Sossenheimer P.H.1, Hirsch A.1, Hurst R.D.2, Cohen R.D.1, Hyman N.2, Rubin D.T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P389: Switching infliximab to subcutaneous from intravenous therapy (SWIMSUIT) – A prospective, real-world, single centre, phase IV interventional study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rahmany, S.(1)*;Young, D.(1);Moyses, H.(2);Gonclaves, J.(3);Latter, S.(4);Cummings, F.(1,5);
Created: Friday, 14 July 2023, 11:05 AM
P389: Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Steenstraten1, K. Sebib Korkmaz1, P. Trivedi3,4,5,6, A. Inderson1, B. van Hoek1, M. Rodriguez Girondo7, J. Maljaars*1

Created: Friday, 22 February 2019, 9:41 AM
P389: The value of oxidative stress parameters to predict histological severity in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Canbakan*1, K. Atay1, E. Koroglu1, M. Tuncer1, H. Senturk2

Created: Friday, 22 February 2019, 9:49 AM
P390 New features of molecular diagnostics of the regulation of molecular apoptotic pathway in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.A. Iakovlev, A. Volkov, I. Shcherbakova, G. Tarasova, S. Malakhanov, O. Bashtovaya

Created: Thursday, 30 January 2020, 10:12 AM
P390: Diverting Loop Ileostomy in Medically Refractory Crohn's Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Patel, P.(1);Wu, L.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P390: Efficacy and safety of mesenchymal stem cell therapy with darvadstrocel for complex perianal fistulizing Crohn´s disease: multicentric experience in the Basque Country and Navarre
Year: 2022
Source: ECCO'22
Authors: Elorza, A.(1);Arzallus, T.(2);Izagirre, A.(2);Vicuña, M.(3);Rodriguez, C.(3);Cabriada, J.L.(1);Rodriguez-Lago, I.(1);
Created: Friday, 11 February 2022, 3:52 PM
P390: Methotrexate is not superior to placebo in maintaining remission in patients with ulcerative colitis: results from the MERIT-UC study
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Herfarth1*, E.L. Barnes1, S. Jackson1, J.F. Valentine2, J. Hanson3, P.D.R. Higgins4, K.L. Isaacs1, M.T. Osterman5, B.E. Sands6, J.D. Lewis5, MERIT-UC study group

Created: Thursday, 21 February 2019, 9:14 AM
P390: Open-label study to evaluate the pharmacokinetics of fidaxomicin in inflammatory bowel disease patients with Clostridium difficile infection (the PROFILE study): pharmacokinetics analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Högenauer C.1, Mahida Y.2, Stallmach A.3, Marteau P.4, Rydzewska G.5, Ivashkin V.6, Gargalianos-Kakolyris P.7, Michon I.8, Adomakoh N.9, Reinisch W.*10

Created: Wednesday, 20 February 2019, 10:36 AM
P390: The impact of anti-TNF therapy in adjuvant setting on postoperative recurrence patterns over decades in complicated Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Colombo*1, A. Frontali2, L. Conti1, C. Baldi1, S. Ardizzone3, G. Maconi3, F. Corsi4, D. Foschi1, G. M. Sampietro1

Created: Friday, 22 February 2019, 9:41 AM
P390: To double dose or not to double dose? That is the question: Single centre experience in the use of infliximab antibodies and levels in a paediatric IBD (pIBD) cohort
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Huggett*, S. Sider, S. Chadokufa, N. Acton, N. Shah, F. Kiparissi

Created: Friday, 22 February 2019, 9:49 AM
P390: Ustekinumab modulates IL-12 and IL-23-related cell type-specific inflammatory transcriptional states in Ulcerative Colitis induction therapy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Richards, D.(1)*;Venkat, S.(1);Freeman, T.C.(1);Mcrae, B.(1);Hoops, T.(1);Marano, C.(1);Branigan, P.(1);
Created: Friday, 14 July 2023, 11:05 AM
P391 Side-to-side strictureplasty and its modification over the ileocecal valve for extensive Crohn’s ileitis: single-centre long-term outcome
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Bislenghi1, M. Ferrante2, J.P.G. Sabino2, B. Verstockt2, B. Martin Perez1, A. Wolthuis1, S. Vermeire2, A. D’hoore1

Created: Thursday, 30 January 2020, 10:12 AM
P391: Antibiotics in pediatric Inflammatory Bowel Diseases: a systematic review
Year: 2021
Source: ECCO'21 Virtual
Authors: Verburgt, C.(1,2);Heutink, W.P.(3);Kuilboer, L.I.M.(1);Dickmann, J.D.(1);van Etten-Jamaludin, F.S.(4);Benninga, M.A.(1);de Jonge, W.J.(2,5);Van Limbergen, J.E.(1,2,6);Tabbers, M.M.(1);
Created: Wednesday, 2 June 2021, 4:12 PM